CGP 52608

Known as: CGP-52608, CGP52608 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2017
012319952017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
OBJECTIVES Melatonin may influence directly tumor cells through the specific binding sites. The best known melatonin binding… (More)
Is this relevant?
2004
2004
Oncostatic activity of CGP 52608 at concentrations 1 microM or lower, and cytotoxicity at 5 and 10 microM, are showed in central… (More)
Is this relevant?
2001
2001
The effects of melatonin and the thiazolinidinedione derivative CGP 52608 on apoptosis of Colon 38 cancer cells were investigated… (More)
Is this relevant?
2000
2000
The report shows that melatonin enhances IL-2 and IL-6 production by two human lymphocytic (Jurkat) and monocytic (U937) cell… (More)
Is this relevant?
1999
1999
The antiproliferative effects of melatonin and CGP 52608, an exogenous ligand for RZR/ROR receptors, are compared in the present… (More)
Is this relevant?
1999
1999
Melatonin is reported to reduce proliferation in many cell types, but the effect is small and the results are inconsistent… (More)
Is this relevant?
1998
1998
The thiazolidinedione BRL 49653 and the thiazolidinedione derivative CGP 52608 are lead compounds of two pharmacologically… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1998
1998
The pineal gland hormone melatonin is well known as a regulator of circadian rhythmicity, but has also other functions in the… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
This paper shows that melatonin is able to activate human Th1 lymphocytes by increasing the production of IL-2 and IFN-gamma in… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Many important physiological functions are controlled by hormones via binding and activating members of the nuclear receptor… (More)
Is this relevant?